In selected groups of patients with atrial fibrillation, ablation can lead to an improvement in symptoms and/or prognosis. To avoid complications, anticoagulation before, during and after ablation should be criteria-driven. There is a consensus that periprocedural oral anticoagulation (OAC) is generally recommended regardless of the thromboembolic risk. On the other hand, the longer-term continuation of OAC is controversial. The ALONE-AF study published in 2025 has provided new evidence in this regard.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Gestational diabetes
Significant CVD prevention through five lifestyle factors
- Modern therapeutic approaches for melanoma
Innovative strategies to overcome immunotherapy resistance
- Irritable Bowel Syndrome
“Best practice” recommendations for step-by-step clarification and stage-adapted therapy
- Nutritional supplements and cognition
5-HTP: The serotonin booster for cognition in old age
- Pulmonary hypertension
PH and lung diseases
- CRC, AML and melanoma in focus
Molecular mechanisms of tumor plasticity
- Friedreich's ataxia
Interim analyses of the PROFA study show “Unmet needs”
- Hepatitis B prophylaxis